GINS2 has been found to be closely related to cell proliferation, survival and maintenance of genomic integrity in addition to the induction of polyploidy. However, the molecular mechanisms of GINS2-mediated tumor regression have not been fully elucidated. Our study showed that GINS2
interacted with PML-C (a structural domain of PML, which is a cutting product of PML-RARα) as demonstrated by yeast two-hybrid assay and co-immunoprecipitation, and PML (NLS-) also interacted with GINS2 by co-immunoprecipitation. Following transfection with plasmids expressing GINS2
siRNA, the apoptosis and cell cycle distribution were determined by flow cytometry. The results revealed that K562 chronic myelocytic leukemia cells and NB4 acute promyelocytic leukemia cells were arrested in the G2 phase. Western blot assay indicated that the expression of cyclin A,
cyclin D1 and cyclin B1 was decreased, and cyclin B1 was localized in the cytoplasm after GINS2 knockdown as demonstrated by immunofluorescence staining. The expression of the apoptosis-related protein Bcl-2 was decreased but that of Bax was increased in the cells transfected
with GINS2 siRNA. The percentage of apoptotic cells was increased as detected by flow cytometry. Our findings demonstrated that GINS2 plays an important role in apoptosis and may function via the p38MAPK signaling pathway.
No Reference information available - sign in for access.
No Citation information available - sign in for access.
No Supplementary Data.
No Article Media
Document Type: Research Article
Central Laboratory of Yangchuan Hospital, Chongqing Medical University, Chongqing 400016, P.R. China
Hebei Chest Hospital, Hebei 050041, P.R. China
Key Laboratory of the Laboratory of Medical Diagnostics, Ministry of Education, Chongqing Medical University, Chongqing 400016, P.R. China
January 1, 2013
More about this publication?
The International Journal of Molecular Medicine is a monthly, peer-reviewed journal devoted to the publication of high quality studies related to the molecular mechanisms of human disease. The journal welcomes research on all aspects of molecular and clinical research, ranging from biochemistry to immunology, pathology, genetics, human genomics, microbiology, molecular pathogenesis, molecular cardiology, molecular surgery and molecular psychology.
The International Journal of Molecular Medicine aims to provide an insight for researchers within the community in regard to developing molecular tools and identifying molecular targets for the diagnosis and treatment of a diverse number of human diseases.
- Editorial Board
- Information for Authors
- Submit a Paper
- Subscribe to this Title
- Information for Advertisers
- Terms & Conditions
- Ingenta Connect is not responsible for the content or availability of external websites